In addition, studies have shown that knockdown of UBE2S promotes apoptosis, inhibits cell proliferation, and inhibits the mTOR signaling pathway in vitro and in vivo, thereby ultimately inhibiting the tumor progression of bladder cancer (Tang et al. 2021). Here, UBE2S is linked to urinary bladder carcinoma.